Aethlon Medical
AEMD
7 hedge funds and large institutions have $851K invested in Aethlon Medical in 2017 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, reducing their positions, and 2 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
22% less funds holding
Funds holding: 9 → 7 (-2)
55% less capital invested
Capital invested by funds: $1.88M → $851K (-$1.03M)
Top Buyers
| 1 |
BlackRock
New York
|
+$278K |
| 2 |
Bank of New York Mellon
New York
|
+$46.3K |
Top Sellers
| 1 |
CFN
Cordasco Financial Network
Naples,
Florida
|
-$857K |
| 2 |
Lido Advisors
Los Angeles,
California
|
-$41K |
| 3 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$2K |
| 4 |
Morgan Stanley
New York
|
-$1K |
AEMD Hedge Fund Activity: Q1 2017 in Review
7 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q1 2017, worth a combined $851K — down 55% from $1.88M a quarter earlier.
Fund positioning in AEMD was balanced in Q1 2017: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 0 trimmed.
The largest buyer was BlackRock, opening a new position worth an estimated $278K. The largest seller was Cordasco Financial Network, exiting entirely with an estimated $857K sold.
- 7 institutional investors held Aethlon Medical (AEMD) as of Q1 2017, down from 9 in Q4 2016.
- Funds reported $851K of Aethlon Medical stock for Q1 2017, down 55% quarter-over-quarter.
- 2 funds opened new Aethlon Medical positions in Q1 2017 and 2 closed out, a net change of 0 holders.
- The largest Aethlon Medical buyer in Q1 2017 was BlackRock, an estimated $278K added.
- The largest Aethlon Medical seller in Q1 2017 was Cordasco Financial Network, an estimated $857K sold.
Based on aggregated 13F filings for Q1 2017.